The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126363771 12636377 1 I 201403 20160502 20160809 20160809 EXP US-BAYER-2016-090057 BAYER 85.00 YR E F Y 0.00000 20160809 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126363771 12636377 1 SS XARELTO RIVAROXABAN 1 Oral 20 MG, UNK Y UNKNOWN 0 20 MG FILM-COATED TABLET
126363771 12636377 2 SS XARELTO RIVAROXABAN 1 Oral 20 MG, UNK Y UNKNOWN 0 20 MG FILM-COATED TABLET
126363771 12636377 3 SS XARELTO RIVAROXABAN 1 Y 0 FILM-COATED TABLET
126363771 12636377 4 PS ACETYLSALICYLIC ACID({=100 mg) ASPIRIN 1 81 MG, UNK Y 999999 81 MG CHEWABLE TABLET
126363771 12636377 5 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral 75 MG, UNK Y 0 75 MG
126363771 12636377 6 C ASCORBIC ACID. ASCORBIC ACID 1 Unknown UNK 0
126363771 12636377 7 C ATORVASTATIN ATORVASTATIN 1 Unknown UNK 0
126363771 12636377 8 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Unknown UNK 0
126363771 12636377 9 C COLECALCIFEROL CHOLECALCIFEROL 1 Unknown UNK 0
126363771 12636377 10 C DABIGATRAN DABIGATRAN 1 Unknown UNK 0
126363771 12636377 11 C POLYETHYLENE GLYCOL POLYETHYLENE GLYCOLS 1 Unknown UNK 0
126363771 12636377 12 C SOLIFENACIN SOLIFENACIN 1 Unknown UNK 0
126363771 12636377 13 C CALCIUM CALCIUM 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126363771 12636377 1 Thrombosis prophylaxis
126363771 12636377 2 Cerebrovascular accident prophylaxis
126363771 12636377 3 Atrial fibrillation
126363771 12636377 4 Product used for unknown indication
126363771 12636377 5 Product used for unknown indication
126363771 12636377 6 Product used for unknown indication
126363771 12636377 7 Product used for unknown indication
126363771 12636377 8 Product used for unknown indication
126363771 12636377 9 Product used for unknown indication
126363771 12636377 10 Product used for unknown indication
126363771 12636377 11 Product used for unknown indication
126363771 12636377 12 Product used for unknown indication
126363771 12636377 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126363771 12636377 HO
126363771 12636377 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126363771 12636377 Cardiac disorder
126363771 12636377 Fall
126363771 12636377 Haemorrhagic diathesis
126363771 12636377 Internal haemorrhage
126363771 12636377 Subdural haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126363771 12636377 1 20010605 0
126363771 12636377 2 20131227 201403 0
126363771 12636377 4 201406 0
126363771 12636377 5 201406 0